Skip to main content
Erschienen in: Diabetologia 8/2003

01.08.2003 | Article

The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens

verfasst von: K. Sadeharju, M. Knip, M. Hiltunen, H. K. Åkerblom, H. Hyöty

Erschienen in: Diabetologia | Ausgabe 8/2003

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Enterovirus infections are among the environmental risk factors potentially contributing to the pathogenesis of Type 1 diabetes. The aim of this study was to evaluate virus-host interaction by analysing the enterovirus antibody levels in subjects carrying different HLA-DR alleles associated with either increased or decreased risk of Type 1 diabetes.

Methods

Antibodies against coxsackievirus B4 were measured to study immune responses induced by natural enterovirus infections and against poliovirus 1 to study immune responses induced by immunisation by enterovirus antigens (vaccine). Antibodies against the mumps virus were measured as a control. Study subjects included siblings of children with Type 1 diabetes taking part in the Childhood Diabetes in Finland (DiMe) Study and carrying either HLA-DR risk (DR3 and/or DR4) or protective (DR2) alleles.

Results

Children with either the HLA-DR3 or HLA-DR4 allele and those with both these risk alleles had higher Coxsackie B4 antibody levels than children carrying the HLA-DR2 allele (p=0.01, p=0.01 and p=0.008, respectively). High responders (IgG levels higher than 75 percent) were also more frequent among genetically susceptible children compared to children with the protective DR2 allele (27% vs 12%) (p<0.009). The same trend was seen for poliovirus antibodies, while mumps antibody levels had a different pattern (high responders more common among DR2-positive subjects).

Conclusions/interpretation

Diabetes-associated HLA-DR risk alleles were associated with a strong immune responsiveness and protective alleles with a weak responsiveness against enterovirus antigens. This phenomenon should be taken into consideration in serological case-control studies and it might play a role in virus-induced beta-cell damage.
Literatur
1.
Zurück zum Zitat D'Alessio DJ (1992) A case-control study of group B coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am J Epidemiol 135:1331–1338PubMed D'Alessio DJ (1992) A case-control study of group B coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am J Epidemiol 135:1331–1338PubMed
2.
Zurück zum Zitat Lönnrot M, Korpela K, Knip M et al. (2000) Enterovirus infection as a risk factor for beta-cell autoimmunity in the prospective birth-cohort trial DIPP. Diabetes 49:1314–1318PubMed Lönnrot M, Korpela K, Knip M et al. (2000) Enterovirus infection as a risk factor for beta-cell autoimmunity in the prospective birth-cohort trial DIPP. Diabetes 49:1314–1318PubMed
3.
Zurück zum Zitat Hyöty H (2002) Enterovirus infections and type 1 diabetes. Ann Med 34:138–147PubMed Hyöty H (2002) Enterovirus infections and type 1 diabetes. Ann Med 34:138–147PubMed
4.
Zurück zum Zitat Svejgaard A, Platz P, Ryder LP (1983) HLA and disease 1982—a survey. Immunol Rev 70:193–218PubMed Svejgaard A, Platz P, Ryder LP (1983) HLA and disease 1982—a survey. Immunol Rev 70:193–218PubMed
5.
Zurück zum Zitat Ilonen J, Herva E, Tiilikainen A et al. (1978) HLA-Dw2 as a marker of resistance against juvenile diabetes mellitus. Tissue Antigens 11:144–146PubMed Ilonen J, Herva E, Tiilikainen A et al. (1978) HLA-Dw2 as a marker of resistance against juvenile diabetes mellitus. Tissue Antigens 11:144–146PubMed
6.
Zurück zum Zitat Bruserud O, Jervell J, Thorsby E (1985) HLA-DR 3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia 28:420–426PubMed Bruserud O, Jervell J, Thorsby E (1985) HLA-DR 3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia 28:420–426PubMed
7.
Zurück zum Zitat Schernthaner G, Banatvala JE, Scherbaum W et al. (1985) Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens and C-peptide secretion in insulin-dependent diabetes mellitus. Lancet 9:630–632 Schernthaner G, Banatvala JE, Scherbaum W et al. (1985) Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens and C-peptide secretion in insulin-dependent diabetes mellitus. Lancet 9:630–632
8.
Zurück zum Zitat Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al. (1992) Epidemiology of childhood diabetes mellitus in Finland—background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:70–76PubMed Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al. (1992) Epidemiology of childhood diabetes mellitus in Finland—background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:70–76PubMed
9.
Zurück zum Zitat Peltola H, Karanko V, Kurki T et al. (1986) Rapid effect on endemic measles, mumps and rubella of nationwide vaccination programme in Finland. Lancet I:137–139 Peltola H, Karanko V, Kurki T et al. (1986) Rapid effect on endemic measles, mumps and rubella of nationwide vaccination programme in Finland. Lancet I:137–139
10.
Zurück zum Zitat Paunio M (1988) Compliance and vaccination coverage. Health Services Research by the National Board of Health in Finland, Helsinki, no 47 (Thesis) Paunio M (1988) Compliance and vaccination coverage. Health Services Research by the National Board of Health in Finland, Helsinki, no 47 (Thesis)
11.
Zurück zum Zitat Hyoty H, Huupponen T, Leinikki P (1985) Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): altered IgA class immune response against mumps virus. Clin Exp Immunol 60:139–144PubMed Hyoty H, Huupponen T, Leinikki P (1985) Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): altered IgA class immune response against mumps virus. Clin Exp Immunol 60:139–144PubMed
12.
Zurück zum Zitat Julkunen I. Hautanen A. Keski-Oja J (1983) Interaction of viral envelope glycoproteins with fibronectin. Infect Immun 40:876–881PubMed Julkunen I. Hautanen A. Keski-Oja J (1983) Interaction of viral envelope glycoproteins with fibronectin. Infect Immun 40:876–881PubMed
13.
Zurück zum Zitat Samuelson A, Glimåker M, Skoog E, Cello J, Forsgren M (1993) Diagnosis of enteroviral meningitis with IgG-EIA using heat-treated virions and synthetic peptides as antigens. J Med Virol 40:271–277PubMed Samuelson A, Glimåker M, Skoog E, Cello J, Forsgren M (1993) Diagnosis of enteroviral meningitis with IgG-EIA using heat-treated virions and synthetic peptides as antigens. J Med Virol 40:271–277PubMed
14.
Zurück zum Zitat Hyöty H, Hiltunen M, Knip M et al. (1995) A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 44:652–657PubMed Hyöty H, Hiltunen M, Knip M et al. (1995) A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 44:652–657PubMed
15.
Zurück zum Zitat Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R (1989) New susceptibility haplotype for type 1 diabetes. DIME Study Group. Lancet ii:299–302 Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R (1989) New susceptibility haplotype for type 1 diabetes. DIME Study Group. Lancet ii:299–302
16.
Zurück zum Zitat Bruserud O,Thorsby E (1985) HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus: studies on healthy individuals and patients with type 1 diabetes. Scand J Immunol 22:509–518PubMed Bruserud O,Thorsby E (1985) HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus: studies on healthy individuals and patients with type 1 diabetes. Scand J Immunol 22:509–518PubMed
17.
Zurück zum Zitat Troye-Blomberg M (2002) Genetic regulation of malaria infection in humans. Chem Immunol 80:243–252PubMed Troye-Blomberg M (2002) Genetic regulation of malaria infection in humans. Chem Immunol 80:243–252PubMed
18.
Zurück zum Zitat Al Jabri AA (2002) HLA and in vitro susceptibility to HIV infection. Mol Immunol 38:959–967CrossRefPubMed Al Jabri AA (2002) HLA and in vitro susceptibility to HIV infection. Mol Immunol 38:959–967CrossRefPubMed
19.
Zurück zum Zitat Hue S, Cacoub P, Renou C et al. (2002) Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Inf Dis 186:106–109CrossRef Hue S, Cacoub P, Renou C et al. (2002) Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Inf Dis 186:106–109CrossRef
20.
Zurück zum Zitat Bertoletti A, Ferrari C, Fiaccadori F (1996) Role of the cell-mediated immune response in the pathogenesis of hepatitis B virus infection: possible immune-therapeutic strategies. Acta Biomed Ateneo Parmense 67:87–93PubMed Bertoletti A, Ferrari C, Fiaccadori F (1996) Role of the cell-mediated immune response in the pathogenesis of hepatitis B virus infection: possible immune-therapeutic strategies. Acta Biomed Ateneo Parmense 67:87–93PubMed
21.
Zurück zum Zitat Konya J, Dillner J (2001) Immunity to oncogenic human papillomaviruses. Adv Cancer Res 82:205–238PubMed Konya J, Dillner J (2001) Immunity to oncogenic human papillomaviruses. Adv Cancer Res 82:205–238PubMed
22.
Zurück zum Zitat Mustonen J, Partanen J, Kanerva M et al. (1998) Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol 47:277–279CrossRefPubMed Mustonen J, Partanen J, Kanerva M et al. (1998) Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol 47:277–279CrossRefPubMed
23.
Zurück zum Zitat Morens D, Pallansch MA (1995) Epidemiology. In: Rotbart HA (ed.) Human enterovirus infections. ASM Press, Washington, pp 3–23 Morens D, Pallansch MA (1995) Epidemiology. In: Rotbart HA (ed.) Human enterovirus infections. ASM Press, Washington, pp 3–23
24.
Zurück zum Zitat Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R and Tuomilehto J (2000) Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23:1516–1526PubMed Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R and Tuomilehto J (2000) Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23:1516–1526PubMed
Metadaten
Titel
The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens
verfasst von
K. Sadeharju
M. Knip
M. Hiltunen
H. K. Åkerblom
H. Hyöty
Publikationsdatum
01.08.2003
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 8/2003
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1157-x

Weitere Artikel der Ausgabe 8/2003

Diabetologia 8/2003 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.